创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Introduction to IC50 Assay Technology

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-11 15:06
  • Views:

(Summary description)InnoModels Biotechnology has always been committed to providing cutting-edge biotechnology solutions to support scientists in the fields of drug discovery and disease research. Among them, the IC50 (half inhibitory concentration) measurement technology is an important innovation in the company's biological research, which provides accurate and reliable data support for key steps in the drug screening and development process.

InnoModels Biotechnology: Introduction to IC50 Assay Technology

(Summary description)InnoModels Biotechnology has always been committed to providing cutting-edge biotechnology solutions to support scientists in the fields of drug discovery and disease research. Among them, the IC50 (half inhibitory concentration) measurement technology is an important innovation in the company's biological research, which provides accurate and reliable data support for key steps in the drug screening and development process.

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-11 15:06
  • Views:
Information

InnoModels Biotechnology has always been committed to providing cutting-edge biotechnology solutions to support scientists in the fields of drug discovery and disease research. Among them, the IC50 (half inhibitory concentration) measurement technology is an important innovation in the company's biological research, which provides accurate and reliable data support for key steps in the drug screening and development process.
Definition of IC50
IC50 is the concentration of a drug or compound required to inhibit biological activity by half. It is a commonly used bioactivity assay parameter to assess the inhibitory effect of a compound on biological targets, such as enzyme activity, cell proliferation, etc. The lower the IC50 value, the stronger the inhibitory effect of the compound on the target.
InnoModels Bio's IC50 assay technology
InnoModels's IC50 assay technology provides researchers with a highly accurate, high-throughput assay solution. Below are some of the remarkable features of the technology:
1. Multi-disciplinary applicability:
InnoModels's IC50 assay technology covers a wide range of research areas, including drug discovery, life science research, and more. Whether it is for enzyme, cell, or other biomolecule activity measurement, it can provide reliable IC50 values.
2. High sensitivity:
The company adopts advanced testing instruments and sensitive bioanalytical techniques to ensure that even low concentrations of drugs or compounds can be measured accurately, which improves the credibility of experimental data.
3. Fast and efficient:
InnoModels Bio's IC50 solution is not only highly accurate, but also optimised in terms of experimental cycle time to improve the efficiency of experiments and enable researchers to obtain critical data faster.
4. Customised services:
We offer customised IC50 assay services, designed to meet the specific needs of our customers, ensuring that the unique requirements of different research projects are met to the greatest extent possible.

 


Application Areas
InnoModels Bio's IC50 assay technology has been widely used in the following areas:
Drug screening and optimisation:
Through IC50 assays, scientists are able to assess the inhibitory effects of potential drug candidates to optimise drug design and development.
Biological Research:
In biological studies, the determination of IC50 values helps researchers gain insight into the function and interaction of biomolecules.
Toxicity Assessment:
Evaluation of the toxicity of compounds in living organisms is an important application of IC50 determination in toxicological studies.
Conclusion
InnoModels Bio's IC50 assay technology is not only an innovation in the field of biological research, but also provides a reliable tool for drug discovery and development. Through continuous technological innovation and service optimisation, the company will continue to play a leading role in the field of IC50 assay, providing scientists with more advanced and efficient research tools to promote the continuous progress of science.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司